Maverick Capital’s Atara Biotherapeutics ATRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-251,629	Closed	-$9.31M	–	361
2023 Q3	$9.31M	Hold	251,629	–	–	0.22%	48
2023 Q2	$10.1M	Hold	251,629	–	–	0.22%	48
2023 Q1	$18.2M	Sell	251,629 -12	-0%	-$1.16K	0.47%	34
2022 Q4	$20.6M	Sell	251,641 -62,592	-20%	-$6.52M	0.5%	36
2022 Q3	$29.7M	Hold	314,233	–	–	0.67%	31
2022 Q2	$61.2M	Hold	314,233	–	–	1.53%	15
2022 Q1	$73M	Hold	314,233	–	–	1.31%	19
2021 Q4	$124M	Hold	314,233	–	–	1.5%	17
2021 Q3	$141M	Buy	314,233 +6,046	+2%	+$2.17M	1.55%	16
2021 Q2	$120M	Buy	308,187 +38,611	+14%	+$13.8M	1.13%	15
2021 Q1	$96.8M	Sell	269,576 -23,406	-8%	-$10.3M	0.91%	23
2020 Q4	$144M	Buy	292,982 +23,130	+9%	+$10.7M	2.3%	16
2020 Q3	$87.4M	Sell	269,852 -312	-0.1%	-$106K	1.63%	21
2020 Q2	$98.4M	Buy	270,164 +62,168	+30%	+$15.7M	2.07%	14
2020 Q1	$44.3M	Buy	207,996 +9,659	+5%	+$3.07M	0.93%	27
2019 Q4	$81.7M	Sell	198,337 -5,822	-3%	-$2.01M	1.19%	21
2019 Q3	$72.1M	Buy	204,159 +114,860	+129%	+$42.9M	1.06%	23
2019 Q2	$44.9M	Buy	89,299 +54,468	+156%	+$38.4M	0.65%	30
2019 Q1	$34.6M	Buy	+34,831	New	+$32.4M	0.46%	40